Patients with A3669G polymorphism of the GR gene, which has been connected with GC resistance, have been reported to be at elevated risk of enlarged heart, systolic dysfunction, CAD, and heart failure (HF) [20,21]. Here, NR3C1 is linked to coronary artery disorder.